Quarterly Results December 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gian Life Care reported a weak set of numbers for Q3 FY26 with revenue from operations of ₹112.28 lakhs, down from ₹158.86 lakhs in the year-ago quarter. For the nine months ended December 2025, revenue nearly halved to ₹264.98 lakhs from ₹551.76 lakhs in the same period last year. The company slipped into a loss of ₹28.54 lakhs (standalone) and ₹35.51 lakhs (consolidated) for the nine-month period, compared to profits of ₹63.18 lakhs and ₹56.12 lakhs respectively last year. The auditor issued a qualified review report, flagging an unverified cash balance of ₹743.78 lakhs along with unpaid statutory dues of ₹426.66 lakhs and a bank loan of ₹359.78 lakhs that has been classified as a Non-Performing Asset (NPA).
This is a negative filing for shareholders — collapsing revenues, a swing to loss, an NPA-tagged bank loan, unpaid statutory dues, and a qualified auditor opinion together raise serious concerns about the company's financial health and going-concern status. Investors should expect heightened risk and likely negative stock price reaction.